Brain Metastases

December 14, 2015December 14, 2015

FDA Approves Genentech’s ALECENSA as Oral Therapy for Advanced ALK-positive Non-small Cell Lung Cancer

Lung Cancer, News

ALECENSA (alectinib), a therapy commercialized by Genentech, was approved by U.S. Food and Drug Administration for the treatment of patients with advanced (metastatic) ALK-positive non-small cell lung cancer (NSCLC) previously ... Read more

October 16, 2015October 16, 2015

Researchers Find that Lung Cancer Patients with Brain Metastases and Rare Genetic Mutations Have Extended Survival

Lung Cancer, News

A study published in Journal of Clinical Oncology entitled “Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastasis,” finds that patients with lung cancer associated ... Read more